Hospitalization costs associated with warfarin‐related bleeding events among older community‐dwelling adults
- 25 June 2010
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 19 (7) , 731-736
- https://doi.org/10.1002/pds.1953
Abstract
Purpose A prior paper from this study demonstrated that patient report of receiving medication instructions from health care professionals is associated with reduced risk of warfarin-related bleeding hospitalizations. The objective of this analysis was to describe the hospitalization costs due to warfarin-related bleeding events in older community-dwelling adults and to estimate the hospitalization costs avoided due to the receipt of medication instruction from different sources. Methods We estimated the expected hospitalization costs associated with four instruction sources based on the respective incidence rate of observed hospitalizations and mean hospitalization cost for warfarin-related bleeding episodes from a prospective cohort study of beneficiaries of the Pennsylvania Pharmaceutical Assistance Contract for the Elderly (PACE). We estimated hospitalization costs avoided due to each instruction source compared to no instructions using the payer's perspective. We conducted probabilistic sensitivity analysis to account for uncertainty in our parameters. Results One hundred twenty-six warfarin-related bleeding hospitalizations occurred during the observation period with a mean cost of $10 819 (SD: $11 536). The mean expected hospitalization cost from a warfarin-related bleeding hospitalization without instruction was $835 per year per person. Hospitalization costs avoided with instruction from a health care professional ranged from $443 to $481 per year per person. Conclusions The costs per hospitalization associated with warfarin-related bleeding events are substantial. Instructions for warfarin management from a health care professional may reduce the number of warfarin-related bleeding hospitalizations and associated costs. Investments in interventions to improve communication regarding warfarin management may be justified economically based on the potential cost savings estimated in this study. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 10 references indexed in Scilit:
- Patient Reported Receipt of Medication Instructions for Warfarin is Associated with Reduced Risk of Serious Bleeding EventsJournal of General Internal Medicine, 2008
- Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug eventsJournal of Clinical Epidemiology, 2008
- Systematic Review of the Incidence and Characteristics of Preventable Adverse Drug Events in Ambulatory CareAnnals of Pharmacotherapy, 2007
- Bleeding Complications With Warfarin UseArchives of internal medicine (1960), 2007
- Decision Modelling For Health Economic EvaluationPublished by Oxford University Press (OUP) ,2006
- Primary Care: Is There Enough Time for Prevention?American Journal of Public Health, 2003
- Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory SettingJAMA, 2003
- A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving WarfarinAnnals of Internal Medicine, 2000
- The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with WarfarinAnnals of Internal Medicine, 1996
- Probabilistic Sensitivity Analysis Using Monte Carlo SimulationMedical Decision Making, 1985